PL1799844T3 - Sposoby wykrywania obiektów docelowych - Google Patents

Sposoby wykrywania obiektów docelowych

Info

Publication number
PL1799844T3
PL1799844T3 PL05803987T PL05803987T PL1799844T3 PL 1799844 T3 PL1799844 T3 PL 1799844T3 PL 05803987 T PL05803987 T PL 05803987T PL 05803987 T PL05803987 T PL 05803987T PL 1799844 T3 PL1799844 T3 PL 1799844T3
Authority
PL
Poland
Prior art keywords
lactamase
preferred embodiments
cancer
methods
reporters
Prior art date
Application number
PL05803987T
Other languages
English (en)
Inventor
Steven W Sherwood
Original Assignee
Genencor Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genencor Int filed Critical Genencor Int
Publication of PL1799844T3 publication Critical patent/PL1799844T3/pl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/5759—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds localised on the membrane of tumour or cancer cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Radar Systems Or Details Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Oncology (AREA)
  • Iron Core Of Rotating Electric Machines (AREA)
  • Geophysics And Detection Of Objects (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
PL05803987T 2004-09-10 2005-09-09 Sposoby wykrywania obiektów docelowych PL1799844T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US60920504P 2004-09-10 2004-09-10
US60908204P 2004-09-10 2004-09-10
EP05803987A EP1799844B1 (en) 2004-09-10 2005-09-09 Methods for detecting targets
PCT/US2005/032257 WO2006031663A2 (en) 2004-09-10 2005-09-09 Methods for detecting targets

Publications (1)

Publication Number Publication Date
PL1799844T3 true PL1799844T3 (pl) 2010-05-31

Family

ID=36027640

Family Applications (1)

Application Number Title Priority Date Filing Date
PL05803987T PL1799844T3 (pl) 2004-09-10 2005-09-09 Sposoby wykrywania obiektów docelowych

Country Status (10)

Country Link
US (1) US8906637B2 (pl)
EP (1) EP1799844B1 (pl)
AT (1) ATE452987T1 (pl)
DE (1) DE602005018512D1 (pl)
DK (1) DK1799844T3 (pl)
ES (1) ES2337382T3 (pl)
PL (1) PL1799844T3 (pl)
PT (1) PT1799844E (pl)
SI (1) SI1799844T1 (pl)
WO (1) WO2006031663A2 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019111355A1 (ja) * 2017-12-06 2019-06-13 オリンパス株式会社 学習モデル作成方法、画像処理方法、学習モデル作成装置、画像処理装置、学習モデル作成プログラム、及び画像処理プログラム

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4458066A (en) 1980-02-29 1984-07-03 University Patents, Inc. Process for preparing polynucleotides
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US4978613A (en) 1989-01-17 1990-12-18 Abbott Laboratories Beta-lactamase assay employing chromogenic precipitating substrates
US5061620A (en) 1990-03-30 1991-10-29 Systemix, Inc. Human hematopoietic stem cell
US5316906A (en) * 1991-08-23 1994-05-31 Molecular Probes, Inc. Enzymatic analysis using substrates that yield fluorescent precipitates
US5338843A (en) 1992-01-30 1994-08-16 Becton, Dickinson And Company Fluorogenic and chromogenic β-lactamase substrates
US5965132A (en) 1992-03-05 1999-10-12 Board Of Regents, The University Of Texas System Methods and compositions for targeting the vasculature of solid tumors
US5677136A (en) 1994-11-14 1997-10-14 Systemix, Inc. Methods of obtaining compositions enriched for hematopoietic stem cells, compositions derived therefrom and methods of use thereof
WO2004003509A2 (en) * 2002-06-28 2004-01-08 Genepharm, Inc. A method to identify specific interaction between ligand and receptor
US20050227309A1 (en) * 2004-01-21 2005-10-13 Corry Schuyler B Optically-detectable enzyme substrates and their method of use

Also Published As

Publication number Publication date
EP1799844B1 (en) 2009-12-23
DK1799844T3 (da) 2010-04-12
WO2006031663A2 (en) 2006-03-23
HK1106273A1 (en) 2008-03-07
US8906637B2 (en) 2014-12-09
PT1799844E (pt) 2010-03-29
ATE452987T1 (de) 2010-01-15
ES2337382T3 (es) 2010-04-23
SI1799844T1 (sl) 2010-04-30
US20090305307A1 (en) 2009-12-10
WO2006031663A3 (en) 2006-05-11
EP1799844A2 (en) 2007-06-27
DE602005018512D1 (de) 2010-02-04

Similar Documents

Publication Publication Date Title
WO2009067546A3 (en) Lung cancer markers and uses thereof
BRPI0906104B8 (pt) derivado de ácido peptonucleico, composição farmacêutica contendo uma quantidade terapeuticamente eficaz do derivado de ácido peptonucleico, método de utilização do derivado de ácido peptonucleico e composto
US9175043B2 (en) Agents providing controls and standards for immuno-precipitation assays
WO2001077684A3 (en) Proteomic analysis using activity-based probe libraries
BRPI0608376A8 (pt) composição de ligação, método de uso de uma composição de ligação, e, kit de detecção
WO2006128138A3 (en) Biodetection by nucleic acid-templated chemistry
WO2008133728A3 (en) Sequential analysis of biological samples with intermediate bleaching of fluorescence detector
WO2008054600A3 (en) Compositions and methods for biodetection by nucleic acid-templated chemistry
ATE556323T1 (de) Neurofibrilläre marker
WO2001036470A3 (en) Methods and compositions for detection and treatment of breast cancer, based on breast cancer-associated polypeptides
WO2005117973A3 (en) Bispecific binding agents for modulating biological activity
WO2007086904A3 (en) Compositions for use in identification of adenoviruses
BRPI0613382A8 (pt) anticorpos isolados, anticorpo monoclonal, célula de hibridoma, método de identificação, método de inibição do crescimento de uma célula, método de tratamento terapêutico, método de determinação da presença de uma proteína, métodos de diagnósticos da presença de tumor
DK1636586T3 (da) Enzymkatalyseret metaldeponering til foröget in situ-detektion af immunhistokemisker epitoper og nucleinsyresekvenser
WO2020107002A3 (en) Methods for expansion of natural killer (nk) cell subset and related compositions and methods
WO2008060483A3 (en) Protein-protein interaction biosensors and methods of use thereof
WO2006034278A3 (en) Methods and compositions for detecting cancer using components of the u2 spliceosomal particle
WO2004067728A3 (en) Methods and systems for the identification of rna regulatory sequences and compounds that modulate their function
WO2019241594A8 (en) Dota compounds and uses thereof
Cao et al. CrAsH: a biarsenical multi-use affinity probe with low non-specific fluorescence
WO2007123636A3 (en) Compositions and methods comprising the use of cell surface displayed homing endonucleases
WO2009047280A3 (de) Polypeptidmarker zur diagnose von prostatakrebs
WO2006034456A3 (en) Compositions and methods for detecting and treating tumors
PL1799844T3 (pl) Sposoby wykrywania obiektów docelowych
WO2007020522A3 (en) Protein markers for diagnosing of colorectal cancer and use of said markers as drug targets for the treatment of said cancer type